RenovoRx (RNXT) EBITDA Margin Growth (1y) (2026)
Powered by 
Analysis
RenovoRx (RNXT) EBITDA Margin Growth (1y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 146.00 |
| 10 | RenovoRx | 84.43 Mn | 84.43 Mn | 766,000.00 | 26,617.00 |